XML 51 R45.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 28, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of assumptions used in estimating fair value of each option grant The fair value of each option grant made in 2019, 2018 and 2017 was estimated using the following assumptions:
 
2019
 
2018
 
2017
Expected volatility
33.13
%
 
33.39
%
 
33.76
%
Risk-free interest rate
1.69
%
 
2.67
%
 
2.12
%
Expected life from vesting date
3.0 yrs

 
3.0 yrs

 
3.0 yrs

Dividend yield
1.07
%
 
1.07
%
 
1.17
%

Summary of activity of stock plans
Following is a summary of the stock option activity during 2017, 2018 and 2019:
 
Number of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
Outstanding at December 31, 2016
793,173

 
$
122.77

 
 
 
 
Granted
67,965

 
164.35

 
 
 
 
Exercised
(284,574
)
 
121.92

 
 
 
 
Forfeited
(5,942
)
 
104.26

 
 
 
 
Outstanding at December 30, 2017
570,622

 
$
128.34

 
4.66
 
$
21,806

Options vested or expected to vest at December 30, 2017
558,114

 
$
128.00

 
4.63
 
21,517

Options exercisable at December 30, 2017
351,794

 
$
123.90

 
3.94
 
15,005

The weighted average per share fair value of options granted during 2017 was $43.68.
 
Number of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
Outstanding at December 30, 2017
570,622

 
$
128.34

 
 
 
 
Granted
105,135

 
112.08

 
 
 
 
Exercised
(63,717
)
 
106.26

 
 
 
 
Forfeited
(33,627
)
 
129.52

 
 
 
 
Outstanding at December 29, 2018
578,413

 
$
127.74

 
4.35
 
$
909

Options vested or expected to vest at December 29, 2018
565,952

 
$
127.84

 
4.30
 
909

Options exercisable at December 29, 2018
405,128

 
$
126.61

 
3.47
 
909





(12) STOCK-BASED COMPENSATION (Continued)
The weighted average per share fair value of options granted during 2018 was $30.48.
 
Number of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
Outstanding at December 29, 2018
578,413

 
$
127.74

 
 
 
 
Granted
57,648

 
147.31

 
 
 
 
Exercised
(119,789
)
 
113.02

 
 
 
 
Forfeited
(27,712
)
 
137.07

 
 
 
 
Outstanding at December 28, 2019
488,560

 
$
133.13

 
4.04
 
$
9,291

Options vested or expected to vest at December 28, 2019
478,575

 
$
133.21

 
3.99
 
9,078

Options exercisable at December 28, 2019
341,828

 
$
133.32

 
3.19
 
6,470

The weighted average per share fair value of options granted during 2019 was $37.85.
Summary of status of stock options outstanding
Following is a summary of the status of stock options outstanding at December 28, 2019:
Outstanding and Exercisable By Price Range
Options Outstanding
 
Options Exercisable
Exercise Price
Range
 
Number
 
Weighted
Average
Remaining
Contractual
Life
 
Weighted
Average
Exercise
Price
 
Number
 
Weighted
Average
Exercise
Price
$104.47 - 112.08
 
183,658

 
4.59 years
 
$
108.58

 
113,866

 
$
106.43

$123.87 - 132.84
 
70,396

 
1.95 years
 
132.70

 
70,396

 
132.70

$142.67 - 164.35
 
234,506

 
4.24 years
 
152.75

 
157,566

 
152.97

 
 
488,560

 
 
 
 
 
341,828

 
 

Schedule of non-vested stock and restricted stock units During fiscal 2019, 2018 and 2017, the Company granted restricted stock units to directors and certain management employees as follows (which are not included in the above stock plan activity tables):
 
2019
 
2018
 
2017
Shares granted
78,318

 
88,127

 
62,160

Weighted‑average per share price on grant date
$
145.89

 
$
114.89

 
$
163.18

Recognized compensation expense
$
8,815

 
$
6,328

 
$
5,569